PubHealth.info® (An Information Portal on Public Health Issues / Topics, Presented in Collaboration with PakMed Biomedical Solutions)

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]

Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.





YEAR: 1968




CATEGORY: Contraception (Birth Control) and Family Planning



TITLE



Hypertriglyceridemia during treatment with estrogen and oral contraceptives.



AUTHORS

Gershberg H; Hulse M; Javier Z


SOURCE

Obstetrics and Gynecology 31(2): 186-189. February 1968.



ABSTRACT

Impaired glucose tolerance in 49 women taking Envoid (5 mg norethynodrel, .075 mg mestranol) is reported and

evidence that mestranol is the disposing factor is presented. 23 of 38 (61%) women who had taken the drug for more

than 10 months had triglyceride levels greater than 110 mg/100 ml. Generally, triglyceride levels increased with the

duration of treatment. However, cholesterol levels were not markedly increased. Administration of mestranol alone

resulted in a prompt increase in plasma triglyceride levels. Except for 1 woman who had been under long-term

Enovid treatment, triglyceride levels returned to normal soon after discontinuation of treatment. The results suggest

that hypertriglyceridemia resulting from oral contraceptives containing estrogens is due to an alteration in liver

function. (PubHealth.info Document ID: CONT9T 1087-06)



PubHealth.info NOTE: The author(s) of this article titled, "Hypertriglyceridemia during treatment with estrogen and

oral contraceptives.", is(are) Gershberg H; Hulse M; Javier Z. The source of this article is "Obstetrics and

Gynecology 31(2): 186-189. February 1968.". This article was published in 1968 in English language(s).

(PubHealth.info® Document ID: CONT9T 1087-06. All rights reserved with PubHealth.info) PIN: 41087





 

 

Web

PubHealth.info

© Copyrights PubHealth.info®, an information portal on public health. All rights reserved.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.